BG62839B1 - Фармацевтични аерозолни състави - Google Patents

Фармацевтични аерозолни състави Download PDF

Info

Publication number
BG62839B1
BG62839B1 BG101347A BG10134797A BG62839B1 BG 62839 B1 BG62839 B1 BG 62839B1 BG 101347 A BG101347 A BG 101347A BG 10134797 A BG10134797 A BG 10134797A BG 62839 B1 BG62839 B1 BG 62839B1
Authority
BG
Bulgaria
Prior art keywords
composition according
factor
hydrogen
drug
surfactant
Prior art date
Application number
BG101347A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG101347A (en
Inventor
Li Li-Bovet
Keith A. Johnson
Original Assignee
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc. filed Critical Glaxo Wellcome Inc.
Publication of BG101347A publication Critical patent/BG101347A/xx
Publication of BG62839B1 publication Critical patent/BG62839B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
BG101347A 1994-09-28 1997-03-21 Фармацевтични аерозолни състави BG62839B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (2)

Publication Number Publication Date
BG101347A BG101347A (en) 1997-12-30
BG62839B1 true BG62839B1 (bg) 2000-09-29

Family

ID=10762008

Family Applications (1)

Application Number Title Priority Date Filing Date
BG101347A BG62839B1 (bg) 1994-09-28 1997-03-21 Фармацевтични аерозолни състави

Country Status (32)

Country Link
US (1) US5849265A (es)
EP (1) EP0783302B1 (es)
JP (1) JPH10506887A (es)
KR (1) KR100375469B1 (es)
CN (1) CN1084614C (es)
AP (1) AP742A (es)
AT (1) ATE187063T1 (es)
AU (1) AU707922B2 (es)
BG (1) BG62839B1 (es)
BR (1) BR9509108A (es)
CZ (1) CZ286356B6 (es)
DE (1) DE69513671T2 (es)
DK (1) DK0783302T3 (es)
EE (1) EE03380B1 (es)
ES (1) ES2140706T3 (es)
FI (1) FI971279A0 (es)
GB (1) GB9419536D0 (es)
GE (1) GEP20002140B (es)
GR (1) GR3032245T3 (es)
HU (1) HU221856B1 (es)
IS (1) IS1991B (es)
MD (1) MD1900C2 (es)
MX (1) MX9702149A (es)
NO (1) NO313658B1 (es)
NZ (1) NZ292995A (es)
OA (1) OA10603A (es)
PL (1) PL181453B1 (es)
RO (1) RO118564B1 (es)
RU (1) RU2157188C2 (es)
SK (1) SK281519B6 (es)
UA (1) UA47412C2 (es)
WO (1) WO1996009816A1 (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
ATE233084T1 (de) * 1999-04-14 2003-03-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung
US6406745B1 (en) * 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
GB0009606D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
AR032361A1 (es) * 2000-08-05 2003-11-05 Glaxo Group Ltd Derivados de androstano y sales y solvatos de los mismos, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que comprenden tales compuestos, proceso para la preparacion de dichos compuestos, e intermediarios utiles en la preparacion de tales compuestos
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP1318973A2 (en) 2000-09-22 2003-06-18 Glaxo Group Limited Novel alkanoic acid derivatives
GB0106046D0 (en) 2001-03-12 2001-05-02 Glaxo Group Ltd Canister
UA77656C2 (en) * 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
HUP0400070A2 (hu) * 2001-04-30 2004-04-28 Glaxo Group Limited 17alfa-helyzetben ciklusos észtercsoportot tartalmazó androsztán-17béta-karbotiosav-észter-származékok mint gyulladásgátló szerek, eljárás a vegyületek előállítására és ezeket tartalmazó gyógyszerkészítmények
WO2002100879A1 (en) * 2001-06-12 2002-12-19 Glaxo Group Limited Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds
NZ530828A (en) * 2001-08-03 2005-10-28 Glaxo Group Ltd Surfactant and their aerosol formulations for inhalation medicaments
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
US20030140920A1 (en) * 2001-10-26 2003-07-31 Dey L.P. Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
JP2003221335A (ja) 2001-10-26 2003-08-05 Dey Lp 慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
US6702997B2 (en) 2001-10-26 2004-03-09 Dey, L.P. Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
US20030191151A1 (en) * 2001-10-26 2003-10-09 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20030203930A1 (en) * 2001-10-26 2003-10-30 Imtiaz Chaudry Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
NZ533831A (en) * 2002-02-13 2006-04-28 Glaxo Group Ltd Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TWI359675B (en) * 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
CA2534985A1 (en) 2003-08-11 2005-02-24 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
CN1874756B (zh) 2003-08-29 2012-02-29 葛兰素集团有限公司 药用计量剂量吸入器和其相关方法
US7030255B2 (en) * 2004-03-09 2006-04-18 Lyondell Chemical Technology, L.P. Oxidation process with in-situ H202 generation and polymer-encapsulated catalysts therefor
EP1949891A1 (en) 2004-10-12 2008-07-30 Generics (UK) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
ATE404186T1 (de) * 2004-10-12 2008-08-15 Generics Uk Ltd Verfahren zur herstellung von suspensionsaerosolformulierungen, worin die partikel durch präzipition in einem aerosolbehälter gebildet werden
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
CN101677954A (zh) 2007-02-11 2010-03-24 Map药物公司 治疗性施用dhe用于快速减轻偏头痛而使副作用分布最小化的方法
GB0712454D0 (en) * 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69109284T2 (de) * 1990-03-23 1995-08-24 Minnesota Mining & Mfg Verwendung von fluorierten löslichen tensiden zur herstellung von aerosolarzneimitteln mit dosierter abgabe.
WO1992000062A1 (en) * 1990-06-27 1992-01-09 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations

Also Published As

Publication number Publication date
GR3032245T3 (en) 2000-04-27
SK39397A3 (en) 1997-10-08
AU3532195A (en) 1996-04-19
CN1168630A (zh) 1997-12-24
EP0783302B1 (en) 1999-12-01
UA47412C2 (uk) 2002-07-15
KR100375469B1 (ko) 2003-10-17
RO118564B1 (ro) 2003-07-30
DE69513671D1 (de) 2000-01-05
HU221856B1 (hu) 2003-02-28
FI971279A (fi) 1997-03-26
PL319342A1 (en) 1997-08-04
NO971422L (no) 1997-05-23
PL181453B1 (pl) 2001-07-31
OA10603A (en) 2002-08-30
DK0783302T3 (da) 2000-05-29
NO971422D0 (no) 1997-03-25
DE69513671T2 (de) 2000-04-06
MD970134A (en) 1999-02-28
MD1900B2 (en) 2002-04-30
CZ93697A3 (en) 1997-08-13
RU2157188C2 (ru) 2000-10-10
AP742A (en) 1999-04-26
EP0783302A1 (en) 1997-07-16
BR9509108A (pt) 1998-07-14
CN1084614C (zh) 2002-05-15
MX9702149A (es) 1998-04-30
MD1900C2 (ro) 2002-12-31
NO313658B1 (no) 2002-11-11
US5849265A (en) 1998-12-15
JPH10506887A (ja) 1998-07-07
WO1996009816A1 (en) 1996-04-04
AU707922B2 (en) 1999-07-22
FI971279A0 (fi) 1997-03-26
HUT77377A (hu) 1998-04-28
AP9700951A0 (en) 1997-04-30
BG101347A (en) 1997-12-30
SK281519B6 (sk) 2001-04-09
IS4438A (is) 1997-03-10
ES2140706T3 (es) 2000-03-01
EE9700061A (et) 1997-08-15
GB9419536D0 (en) 1994-11-16
IS1991B (is) 2005-02-15
EE03380B1 (et) 2001-04-16
GEP20002140B (en) 2000-06-25
ATE187063T1 (de) 1999-12-15
CZ286356B6 (cs) 2000-03-15
KR970705981A (ko) 1997-11-03
NZ292995A (en) 1998-10-28

Similar Documents

Publication Publication Date Title
BG62839B1 (bg) Фармацевтични аерозолни състави
AU663906C (en) Medicaments
US5955439A (en) Pharmaceutical aerosol containing at least one sugar
US6333023B1 (en) Aerosol formulation containing particulate formoterol, propellant and polar cosolvent
RU2179037C2 (ru) Баллон для доставки фармацевтического состава, дозирующий ингалятор
US5736124A (en) Aerosol formulations containing P134a and particulate medicament
JP3675474B2 (ja) 医薬
JP2004536884A5 (es)
JP2004536884A (ja) 界面活性剤として使用するための化合物
CA2200986C (en) Medicaments